Answers are grounded in this paper and cite their sources.
This article provides an overview on the management of primary immunodeficiency, and discusses the pharmacokinetics of subcutaneous and intravenous immunoglobulin and the relationship between blood levels and therapeutic effects in both treatments. The article will further highlight both treatments' efficacy in preventing infections and the risk of systemic side effects with each treatment.
No takes yet. Share an insight, caveat, or question.
HELBERT et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: